van de Kar NCAJ - Search Results

1

REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study.

Schijvens AM, Dorresteijn EM, Roeleveld N, Ter Heine R, van Wijk JAE, Bouts AHM, Keijzer-Veen MG, van de Kar NCAJ, van den Heuvel LPWJ, Schreuder MF. Schijvens AM, et al. Among authors: van de kar ncaj, van wijk jae, van den heuvel lpwj. BMJ Open. 2017 Sep 27;7(9):e018148. doi: 10.1136/bmjopen-2017-018148. BMJ Open. 2017. PMID: 28963315 Free PMC article. Clinical Trial.

2

Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.

van Setten PA, van Hinsbergh VW, van der Velden TJ, van de Kar NC, Vermeer M, Mahan JD, Assmann KJ, van den Heuvel LP, Monnens LA. van Setten PA, et al. Kidney Int. 1997 Apr;51(4):1245-56. doi: 10.1038/ki.1997.170. Kidney Int. 1997. PMID: 9083293 Free article.

3

Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.

Van Setten PA, van Hinsbergh VW, Van den Heuvel LP, van der Velden TJ, van de Kar NC, Krebbers RJ, Karmali MA, Monnens LA. Van Setten PA, et al. J Am Soc Nephrol. 1997 Dec;8(12):1877-88. doi: 10.1681/ASN.V8121877. J Am Soc Nephrol. 1997. PMID: 9402090

4

Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency.

Assink K, Schiphorst R, Allford S, Karpman D, Etzioni A, Brichard B, van de Kar N, Monnens L, van den Heuvel L. Assink K, et al. Kidney Int. 2003 Jun;63(6):1995-9. doi: 10.1046/j.1523-1755.63.6s.1.x. Kidney Int. 2003. PMID: 12753286 Free article.

5

Is biopsy required prior to cyclophosphamide in steroid-sensitive nephrotic syndrome?

Stadermann MB, Lilien MR, van de Kar NC, Monnens LA, Schröder CH. Stadermann MB, et al. Clin Nephrol. 2003 Nov;60(5):315-7. doi: 10.5414/cnp60315. Clin Nephrol. 2003. PMID: 14640236

6

[From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].

Schiphorst RH, van de Kar NC, van den Heuvel LP. Schiphorst RH, et al. Ned Tijdschr Geneeskd. 2003 Dec 6;147(49):2422-4. Ned Tijdschr Geneeskd. 2003. PMID: 14694551 Review. Dutch.

7

Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).

Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L. Westra D, et al. Nephrol Dial Transplant. 2010 Jul;25(7):2195-202. doi: 10.1093/ndt/gfq010. Epub 2010 Jan 26. Nephrol Dial Transplant. 2010. PMID: 20106822

8

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.

Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC. Westra D, et al. Neth J Med. 2012 Apr;70(3):121-9. Neth J Med. 2012. PMID: 22516576 Free article. Review.

9

Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.

Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L. Volokhina E, et al. Pediatr Nephrol. 2012 Sep;27(9):1519-24. doi: 10.1007/s00467-012-2183-z. Epub 2012 Jun 6. Pediatr Nephrol. 2012. PMID: 22669319 Free PMC article.

10

Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.

Volokhina EB, Westra D, van der Velden TJ, van de Kar NC, Mollnes TE, van den Heuvel LP. Volokhina EB, et al. Clin Exp Immunol. 2015 Aug;181(2):306-13. doi: 10.1111/cei.12426. Clin Exp Immunol. 2015. PMID: 25079699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters